Welcome to the JCRC Site


Contact Us
Plot 101 Upper Lubowa Estates
P O Box 10005, Kampala Uganda
Tel:         +256 414 201147/8
Fax:         +256 414 342632
e-mail:     jcrc@jcrc.co.ug,
            enquiries@jcrc.co.ug
Copyright © 1990 - 2011 Joint Clinical Research Centre. All Rights Reserved.
Joint Clinical Research Centre
For Excellence in Medical Research, Training and HIV Care
JCRC Publications before 2000

Riley JP, Pestano GA, Hosford K, Francis C, Xie JM, Mugyenyi P, Kataaha P, Katongole-Mbidde E, Anokbonggo WW, Guyden J, et al. Relative reactivity of the V3 loop PND of HIV-1 subtypes A, B, C, D, and F with sera from selected Ugandan localities. Arch Virol. 1995;140(8):1393-404. Link

Schwander S, Rüsch-Gerdes S, Mateega A, Lutalo T, Tugume S, Kityo C, Rubaramira R, Mugyenyi P, Okwera A, Mugerwa R. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis. Tuber Lung Dis. 1995 Jun; 76(3):210-8. Link

Tugume SB, Piwowar EM, Lutalo T, Mugyenyi PN, Grant RM, Mangeni FW, Pattishall K, Katongole-Mbidde E. Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol. 1995 Mar;2(2):233-5. Link

Colebunders R, Karita E, Taelman H, Mugyenyi P. Antiretroviral treatment in Africa. AIDS. 1997;11 Suppl B:S107-13. Review. Link
Hom D, Johnson J, Mugyenyi P, Byaruhanga R, Kityo C, Loughlin A, Svilar GM, Vjecha M, Mugerwa R, Ellner J. HIV-1 Risk and Vaccine Acceptability in the Ugandan Military. Journal of AIDS and Human Retroviruses 1997; 15:375-80. Link 

Schwander SK, Dietrich M, Mugyenyi P, Kityo C, Okwera A, Johnson J, Nsubuga P, Ruesch-Gerdes S, Whalen C. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy. East Afr Med J. 1997 Sep;74(9):543-8. Link

Whalen CC, Johnson JL, Okwera A, Hom DL, Mugyenyi P, Kityo C, Mugerwa RD, Ellner JJ. A Trial of three regimens to prevent tuberculosis in Uganda adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337 (12):801-8. Link

Wieland U, Seelhoff A, Hofmann A, Kühn JE, Eggers HJ, Mugyenyi P, Schwander S. Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda. Gen Virol. 1997 Feb;78 ( Pt 2):393-400. Link

Johnson JL, Nyole S, Okwera A, Whalen CC, Nsubuga P, Pekovic V, Huebner R, Wallis RS, Mugyenyi PN, Mugerwa RD, Ellner JJ. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med. 1998 Dec;158(6):1790-6. Link

Hirsch CS, Toossi Z, Vanham G, Johnson JL, Peters P, Okwera A, Mugerwa R, Mugyenyi P, Ellner JJ. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis. 1999 Apr;179(4):945-53. Link

JCRC Vision and Mission


JCRC Vision: A vibrant self-sustaining Centre of Excellence in Medical Research, Training and Healthcare Services.

JCRC Mission: To conduct Quality Medical Research and Training, provide equitable and sustainable HIV/AIDS care and other health care services in Uganda and other parts of Africa